Ascendis Pharma reports 52-week infant data for TransCon CNP at ESPE
BridgeBio PROPEL 3 data show infigratinib cuts ear infections
ImPact Biotech completes ENLIGHTED Phase 3 for padeliporfin VTP
Caspian Therapeutics launches with $50m to target diabetes
Sobi wins FDA Fast Track for pacritinib in VEXAS syndrome
Roche wins FDA Priority Review for Enspryng in MOGAD
SOTIO doses first patient in CDH17-targeting ADC trial for CRC
Pharvaris HAE prophylaxis trial hits 83% attack rate reduction
Vaxart secures European patent for oral norovirus vaccine platform
Novo Nordisk: semaglutide clears obesity threshold in 40% of children
Novartis pelacarsen Phase III trial fails to cut CV events
Globus Medical wins CE Mark for Excelsius3D imaging system in EU and UK
Magrabi Health earns first global SRC Network of Excellence in
ONWARD Medical starts EIGER implant study for spinal cord injury
Tangram Therapeutics advances TGM-312 into MASH patient cohorts
